Saccharomyces boulardii is a probiotic yeast naturally present in the environment, used for several decades for its benefits. Unlike conventional bacterial probiotics, this yeast Saccharomyces boulardiiis distinguished by its fungal structure, which confers particular resistance to variations in the digestive environment and to antibiotic treatments.
In certain physiological situations – such as antibiotic-associated diarrhoea, post-antibiotic diarrhoea, or certain chronic digestive disorders, including conditions such as digestive candidiasis – the intestinal ecosystem may become unbalanced. An imbalanced intestinal microbiota may then be accompanied by impaired digestive comfort, altered bowel transit and increased intestinal sensitivity.
TEOLIANCE®Saccharomyces boulardiistands out for its specific functional profile and its relevance in targeted situations. Its use forms part of a rational and targeted approach, in line with current knowledge on probiotic yeasts.
Why choose TEOLIANCE®Saccharomyces boulardii ?
TEOLIANCE®Saccharomyces boulardii is based on a controlled dosage of 5 billion CFU (Colony Forming Units administered) per capsule of Saccharomyces boulardii CNCM I-1079, a precisely identified and well-documented strain. This dosage allows targeted use, consistent with an approach of precision probio-therapy, based on the choice of a single strain suited to specific contexts. Derived from a strain of natural origin, isolated from the skins of tropical fruits such as lychee and mangosteen, TEOLIANCE®Saccharomyces boulardii also follows a logic of enhanced naturalness. The yeast Saccharomyces boulardii is encapsulated in 100% plant-based capsules, suitable for vegan diets, and guaranteed free from ingredients based on gluten or lactose, in order to suit a wide range of nutritional profiles. This formulation thus combines dosage precision, rigorous strain selection and appropriate galenic choices, while respecting digestive physiology and the quality requirements specific to food supplements.
What does science say?
Saccharomyces boulardii CNCM I-1079 has been extensively studied scientifically, and its biological mechanism of action is well documented in the literature.
However, to date, no health claim has been approved by European legislation.
Despite the absence of official recognition of specific benefits, this growing interest highlights promising prospects that warrant further in-depth exploration.
The benefits of TEOLIANCE®Saccharomyces boulardii
Saccharomyces boulardii CNCM I-1079: a specific and well-documented probiotic yeast
The strain Saccharomyces boulardii CNCM I-1079 is subject to precise identification and registration within the Collection Nationale de Cultures de Microorganismes (CNCM), ensuring traceability, reproducibility and consistency of the strain used. This characterisation is an essential criterion in the selection of a probiotic yeast Saccharomyces boulardiiintended for targeted use as a food supplement.
The yeast Saccharomyces boulardii belongs to the genus Saccharomyces, the best-known of which is the probiotic strain Saccharomyces cerevisiae, particularly in the fields of bakery and brewing, where its fermentative properties have been exploited for centuries. By contrast, this yeast has been little studied for its potential interactions with human physiology, outside these traditional uses.
The specific variantSaccharomyces cerevisiae var. boulardii was identified at the beginning of the 20th century. Its discovery is attributed to the French microbiologist Henri Boulard, who in 1920, while in Indochina, was interested in isolating new yeast strains suitable for fermentation processes. During his field observations, he noted that certain local populations consumed a traditional preparation based on tropical fruit skins, notably lychee and mangosteen. These fruit skins were used to prepare a tea, from which Henri Boulard succeeded in isolating a particular yeast strain, distinct from the strains of Saccharomyces cerevisiae known at the time. This strain was subsequently named Saccharomyces boulardii, in reference to its discoverer.
Since then, the yeast Saccharomyces boulardii has been the subject of a large number of scientific studies aimed at better understanding the biological characteristics and mechanisms of action of this probiotic yeast. This research has contributed to the recognition of Saccharomyces boulardii as a specific, distinct and widely documented variant within the species Saccharomyces cerevisiae. The strain Saccharomyces boulardii CNCM I-1079, precisely identified and registered, forms part of this scientific and historical continuity as a characterised probiotic yeast, now used in digestive food supplements according to an approach of precision probio-therapy.
Saccharomyces boulardii CNCM I-1079: a resistant probiotic yeast
The strain Saccharomyces boulardii CNCM I-1079 exhibits specific resistance capacities linked to its nature as a probiotic yeast, distinct from conventionally used bacterial probiotics. Its fungal structure confers particular stability in the digestive environment, enabling it to pass through the different stages of the digestive tract without being affected by normal physiological conditions, such as variations in pH or the presence of bile salts.
Unlike bacterial probiotics, the yeast Saccharomyces boulardii is not sensitive to antibiotics, which are often responsible for diarrhoea, explaining the interest shown in this strain in certain contexts. The optimal resistance of the strain Saccharomyces boulardii CNCM I-1079, allowing it to maintain its integrity and viability throughout its digestive passage, is an essential criterion in the selection of a probiotic yeast Saccharomyces boulardiiintended for use as a food supplement. This stability contributes to its relevance within an approach of precision probio-therapy, based on the reasoned choice of a single strain, clearly identified and documented.
Enhanced naturalness
TEOLIANCE®Saccharomyces boulardiiis part of an approach focused on enhanced naturalness, based on the rigorous selection of a precisely identified probiotic yeast.
The strain Saccharomyces boulardii CNCM I-1079 is naturally present in the environment and was isolated from the skins of tropical fruits such as lychee and mangosteen, illustrating its anchoring in natural matrices. TEOLIANCE®Saccharomyces boulardii is offered in the form of 100% plant-based capsules, suitable for vegan diets, and formulated without ingredients based on gluten or lactose.
These galenic choices are intended to facilitate the integration of the product into different nutritional contexts, while meeting current expectations in terms of tolerance. This requirement for naturalness forms part of a holistic vision of supplementation, in which the quality of the strain, the simplicity of the formula and the transparency of the ingredients constitute essential criteria for support that respects usage practices and the regulatory framework applicable to food supplements.
Using advice
1 to 2 capsules, twice a day, 30 minutes before a meal.
Directions for use:
After receipt, store the product in a cool dry place.
Do not swallow the desiccant capsule inside the bottle.
Food supplements should be used as part of a healthy lifestyle and must not be used as a substitute for a varied and balanced diet. Do not exceed recommended daily dose. Keep this product out of the reach of young children.
If using several dietary supplements, ask your healthcare professional for guidance.
Saccharomyces boulardii is a probiotic yeast naturally present in the environment, used for several decades for its benefits. Unlike conventional bacterial probiotics, this yeast Saccharomyces boulardiiis distinguished by its fungal structure, which confers particular resistance to variations in the digestive environment and to antibiotic treatments.
In certain physiological situations – such as antibiotic-associated diarrhoea, post-antibiotic diarrhoea, or certain chronic digestive disorders, including conditions such as digestive candidiasis – the intestinal ecosystem may become unbalanced. An imbalanced intestinal microbiota may then be accompanied by impaired digestive comfort, altered bowel transit and increased intestinal sensitivity.
TEOLIANCE®Saccharomyces boulardiistands out for its specific functional profile and its relevance in targeted situations. Its use forms part of a rational and targeted approach, in line with current knowledge on probiotic yeasts.
Why choose TEOLIANCE®Saccharomyces boulardii ?
TEOLIANCE®Saccharomyces boulardii is based on a controlled dosage of 5 billion CFU (Colony Forming Units administered) per capsule of Saccharomyces boulardii CNCM I-1079, a precisely identified and well-documented strain. This dosage allows targeted use, consistent with an approach of precision probio-therapy, based on the choice of a single strain suited to specific contexts. Derived from a strain of natural origin, isolated from the skins of tropical fruits such as lychee and mangosteen, TEOLIANCE®Saccharomyces boulardii also follows a logic of enhanced naturalness. The yeast Saccharomyces boulardii is encapsulated in 100% plant-based capsules, suitable for vegan diets, and guaranteed free from ingredients based on gluten or lactose, in order to suit a wide range of nutritional profiles. This formulation thus combines dosage precision, rigorous strain selection and appropriate galenic choices, while respecting digestive physiology and the quality requirements specific to food supplements.
What does science say?
Saccharomyces boulardii CNCM I-1079 has been extensively studied scientifically, and its biological mechanism of action is well documented in the literature.
However, to date, no health claim has been approved by European legislation.
Despite the absence of official recognition of specific benefits, this growing interest highlights promising prospects that warrant further in-depth exploration.
The benefits of TEOLIANCE®Saccharomyces boulardii
Saccharomyces boulardii CNCM I-1079: a specific and well-documented probiotic yeast
The strain Saccharomyces boulardii CNCM I-1079 is subject to precise identification and registration within the Collection Nationale de Cultures de Microorganismes (CNCM), ensuring traceability, reproducibility and consistency of the strain used. This characterisation is an essential criterion in the selection of a probiotic yeast Saccharomyces boulardiiintended for targeted use as a food supplement.
The yeast Saccharomyces boulardii belongs to the genus Saccharomyces, the best-known of which is the probiotic strain Saccharomyces cerevisiae, particularly in the fields of bakery and brewing, where its fermentative properties have been exploited for centuries. By contrast, this yeast has been little studied for its potential interactions with human physiology, outside these traditional uses.
The specific variantSaccharomyces cerevisiae var. boulardii was identified at the beginning of the 20th century. Its discovery is attributed to the French microbiologist Henri Boulard, who in 1920, while in Indochina, was interested in isolating new yeast strains suitable for fermentation processes. During his field observations, he noted that certain local populations consumed a traditional preparation based on tropical fruit skins, notably lychee and mangosteen. These fruit skins were used to prepare a tea, from which Henri Boulard succeeded in isolating a particular yeast strain, distinct from the strains of Saccharomyces cerevisiae known at the time. This strain was subsequently named Saccharomyces boulardii, in reference to its discoverer.
Since then, the yeast Saccharomyces boulardii has been the subject of a large number of scientific studies aimed at better understanding the biological characteristics and mechanisms of action of this probiotic yeast. This research has contributed to the recognition of Saccharomyces boulardii as a specific, distinct and widely documented variant within the species Saccharomyces cerevisiae. The strain Saccharomyces boulardii CNCM I-1079, precisely identified and registered, forms part of this scientific and historical continuity as a characterised probiotic yeast, now used in digestive food supplements according to an approach of precision probio-therapy.
Saccharomyces boulardii CNCM I-1079: a resistant probiotic yeast
The strain Saccharomyces boulardii CNCM I-1079 exhibits specific resistance capacities linked to its nature as a probiotic yeast, distinct from conventionally used bacterial probiotics. Its fungal structure confers particular stability in the digestive environment, enabling it to pass through the different stages of the digestive tract without being affected by normal physiological conditions, such as variations in pH or the presence of bile salts.
Unlike bacterial probiotics, the yeast Saccharomyces boulardii is not sensitive to antibiotics, which are often responsible for diarrhoea, explaining the interest shown in this strain in certain contexts. The optimal resistance of the strain Saccharomyces boulardii CNCM I-1079, allowing it to maintain its integrity and viability throughout its digestive passage, is an essential criterion in the selection of a probiotic yeast Saccharomyces boulardiiintended for use as a food supplement. This stability contributes to its relevance within an approach of precision probio-therapy, based on the reasoned choice of a single strain, clearly identified and documented.
Enhanced naturalness
TEOLIANCE®Saccharomyces boulardiiis part of an approach focused on enhanced naturalness, based on the rigorous selection of a precisely identified probiotic yeast.
The strain Saccharomyces boulardii CNCM I-1079 is naturally present in the environment and was isolated from the skins of tropical fruits such as lychee and mangosteen, illustrating its anchoring in natural matrices. TEOLIANCE®Saccharomyces boulardii is offered in the form of 100% plant-based capsules, suitable for vegan diets, and formulated without ingredients based on gluten or lactose.
These galenic choices are intended to facilitate the integration of the product into different nutritional contexts, while meeting current expectations in terms of tolerance. This requirement for naturalness forms part of a holistic vision of supplementation, in which the quality of the strain, the simplicity of the formula and the transparency of the ingredients constitute essential criteria for support that respects usage practices and the regulatory framework applicable to food supplements.
Using advice
1 to 2 capsules, twice a day, 30 minutes before a meal.
Directions for use:
After receipt, store the product in a cool dry place.
Do not swallow the desiccant capsule inside the bottle.
Food supplements should be used as part of a healthy lifestyle and must not be used as a substitute for a varied and balanced diet. Do not exceed recommended daily dose. Keep this product out of the reach of young children.
If using several dietary supplements, ask your healthcare professional for guidance.
Please note that orders over £135 are subject to tax as a result of BREXIT regulations, and orders must be collected from customs offices.
We recommend that you split your order into 2 different ones. All orders over £25 are free of shipping charges.
